aqwam mutahidda ki agency ne writers ko bataya ke woh duwaein jo motapay se lardte hain pehli baar aalmi idaara sehat ( w each o ) ki” zaroori adwiyaat ki fehrist” mein shaamil ki ja sakti hain, jo kam aur darmiyani aamdani walay mumalik mein hukoomat ki kharidari ke faislon ki rahnumai ke liye istemaal hoti hain .
w each o ke musheeron ka aik panel aglay mah shaamil ki jane wali dawaiyon ki nai darkhwaston ka jaiza le ga, jis mein September mein zaroori adwiyaat ki taaza tareen fehrist mojood hai .
motapay ki dawaiyon par ghhor karne ki darkhwast ryast_haye mutahidda mein teen doctoron aur aik muhaqiq ne jama karai thi. yeh novo nordisk ki motapay ki dawa saxenda mein fa-aal jazo liraglutide ka ihata karta hai, jo jald hi patent se bahar aajay ga, jis se sastay aam version ki ijazat hogi .
panel darkhwast ko mustard kar sakta hai ya mazeed shawahid ka intzaar kar sakta hai. w each o ki taraf se سیکسینڈا aur hatmi جنرکس ko fehrist mein shaamil karne ka faisla sehat ki agency ki taraf se aalmi motapay ke liye aik naye nuqta nazar ki nishandahi kere ga .
yeh novo nordisk ki taraf se aik naye, ziyada taaqatwar ilaaj ki raah bhi hamwar kar sakta hai jisay wegovy kaha jata hai jo mustaqbil mein kam aur darmiyani aamdani walay mumalik ke liye tajweez kya jaye .
taham, sehat aama ke kuch mahireen aisi dawaiyon ko aik paicheeda haalat ke hal ke tor par muta-arif karanay ke khilaaf mutnabba karte hain jo abhi tak poori terhan se samajh mein nahi aayi hai .
w each o ke tarjuman ne kaha ke” motapa bohat se mumalik mein sehat ka aik barhta sun-hwa ahem masla hai.” motapay ke ilaaj ke liye duwaein intizam ka sirf aik pehlu hain, yaqeenan, aur rokkk thaam bhi bohat zaroori hai. ”
w each o ne kaha ke mahireen ka panel anay walay mahino mein لیراگلوٹائیڈ ke shawahid par ghhor kere ga. woh mustaqbil mein wazan mein kami ke ilaaj ki deegar aqsam ka wasee tar jaiza bhi le satke hain .
w each o ke mutabiq, duniya bhar mein 650 million se ziyada baaligh afraad motapay ka shikaar hain, jo ke 1975 ki sharah se teen gina ziyada hain, aur taqreeban mazeed 1. 3 billion ka wazan ziyada hai. aksariyat – 70 % – kam aur darmiyani aamdani walay mumalik mein rehti hai .
rasai ko barhana
w each o ki zaroori adwiyaat mein motapay ki dawaiyon ko shaamil karna is abadi ke liye bohat ahmiyat ka haamil ho sakta hai. mahireen ka kehna hai ke 2002 mein each aayi v ki adwiyaat ko fehrist mein shaamil karne se inhen ghareeb mumalik mein aids ke mareezon ke liye ziyada wasee pemanay par dastyab honay mein madad mili .
yell new heaven health se talluq rakhnay wali Amrici muhaqiq dr sanjana گریمیلا, university of California , saan se dr sndip kishwar ne likha,” is waqt, ( fehrist ) mein aisi koi duwaein shaamil nahi hain jo khaas tor par motapay ke jari aalmi boojh ke liye wazan mein kami ko nishana banati hain.” Francisco , aur who ke sathiyon ne izafay ki darkhwast ki. unhon ne tabsarah karne ke liye writers ki darkhwaston ka jawab nahi diya .
un ka istadlaal hai ke agarchay fehrist mein ghizaiyat ki kami ke liye maadni سپلیمنٹس shaamil hain, wazan mein kami ke ilaaj ki kami aalmi sehat ki ایکوئٹی mein aik” tazaad” ki numaindagi karti hai, kyunkay ghareeb mumalik mein wazan se mutaliq bimarion se taizi se honay wali amwaat ki barhti hui tadaad ko dekhte hue, dil ki bemari aur diabities
سیکسینڈا, jo rozana aik baar lagaya jata hai, logon ko un ke jismani wazan ka 5 % -10 % kam karne mein madad karta hai, ryast_haye mutahidda mein $ 450 fi maheena aur Europe mein $ 150 fi maheena .
ویگووی istemaal karne walay log, aik hafta waar injection jis ki qeemat ryast_haye mutahidda mein aik mah mein $ 1, 300 se ziyada hai, –apne wazan ka 15 % tak kam kar chuke hain. is waqt, ویگووی ki supply bohat kam hai aur nvo America aur deegar Ameer baazaaron mein –apne aaghaz aur taqseem ko tarjeeh day raha hai .
Denmark ki dawa saaz company ne aik bayan mein kaha ke woh w each o ki fehrist mein shaamil karne ke liye لیراگلوٹائڈ par ghhor karne ki darkhwast mein shaamil nahi tha, unhon ne mazeed kaha,” hum w each o ke jaizay ka khirmqdm karte hain aur parhnay aur faislay ke muntazir hain. ”
dono duwaein dawaiyon ke aik tabqay se talluq rakhti hain jinhein glp-1 ریسیپٹر ایگونسٹ kehte hain, jo diabities ke ilaaj ke liye barson se istemaal hoti rahi hain. yeh dimagh mein bhook ke signals ko mutasir karte hain aur is raftaar ko kam karte hain jis se 1 shakhs ka pait khaali hota hai, jis se woh ziyada der tak pait bhara mehsoos karte hain. eli lilly and co ( lly. n ) ke paas diabities ki aisi hi dawa hai jo wazan kam karne ki manzoori ke qareeb hai .
سکسینڈا aur ویگووی dono ke liye, motapay ke liye taweel mudti hifazat aur taseer ke data ki kami hai. mtalaat se pata chalta hai ke wazan kam rakhnay ke liye logon ko saari zindagi duwaein lena parrin gi .
ziyada aamdani walay mumalik un dawaiyon ko istemaal karne ke tareeqay ke baray mein mukhtalif tareeqay ikhtiyar kar rahay hain, jis mein yeh ghhor karna bhi shaamil hai ke aaya un ko hukoomat ke zair e ihtimaam sehat ke nizaam ke zariye tajweez kya ja sakta hai ya insurance ke zariye cover kya ja sakta hai, kyunkay woh diabities ke liye hain. kuch mumalik mein, un ka istemaal sirf sab se ziyada khatray walay groupon ke liye makhsoos kya ja raha hai .
university of Toronto mein motapay ke maahir professor Zulfiqar bhutta ne kaha ke kam aur darmiyani aamdani walay mumalik mein motapay ke rujhan ko behtar tareeqay se samjhna zaroori hai taakay amal ke behtareen tareeqa ka taayun kya ja sakay .
unhon ne kaha,” taleem ki rokkk thaam ki hikmat e amli aur musalsal koshishen, sanfi tawajah markooz karne wali mdakhlton ko motapay ki adwiyaat ke istemaal par tarjeeh di jani chahiye, jis ke liye hifazat aur taseer ke liye bohat ziyada tehqeeq ki zaroorat hai. “